NSG 6005 ADVANCED PHARMACOLOGY EXAM –
QUESTIONS AND ANSWERS | VERIFIED AND WELL
DETAILED ANSWERS | PLUS RATIONALES |
GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains
Pharmacokinetics and Pharmacodynamics
Advanced Cardiovascular Pharmacology
Psychopharmacology and Neurology
Antimicrobial Stewardship and Infectious Disease
Endocrine and Metabolic Pharmacology
Pharmacogenomics and Precision Medicine
Legal and Ethical Prescribing Practices
Pain Management and Substance Use Disorders
Geriatric and Pediatric Considerations
Introduction
,This assessment is designed to evaluate the advanced
nursing student's proficiency in clinical pharmacology and
safe prescribing practices. The exam covers foundational
theoretical principles, such as drug metabolism and receptor
affinity, while emphasizing the practical application of
pharmacotherapeutics in diverse patient populations.
Students will be assessed on their ability to navigate complex
clinical scenarios, adhere to regulatory and legal standards,
and exercise sound ethical judgment in medication
management. The multi-choice format integrates critical
thinking and evidence-based decision-making to ensure
candidates are prepared for the rigors of advanced practice
and real-world clinical environments.
SECTION ONE: QUESTIONS 1–100
1. A patient with chronic kidney disease (CKD) requires a
medication that is primarily cleared by the kidneys.
Which pharmacokinetic process is most significantly
altered?
A. Absorption
B. Distribution
,C. Metabolism
D. Elimination
🟢 Correct answer D. Elimination
🔴 Explanation: Elimination refers to the removal of a drug
from the body, primarily through the kidneys. In CKD, the
glomerular filtration rate is reduced, leading to decreased
clearance and a higher risk of toxicity.
2. A patient is prescribed a drug with a high first-pass
effect. Which route of administration would result in the
lowest bioavailability?
A. Oral
B. Sublingual
C. Intravenous
D. Transdermal
🟢 Correct answer A. Oral
🔴 Explanation: The first-pass effect occurs when a drug is
metabolized by the liver after being absorbed from the
gastrointestinal tract but before reaching systemic circulation.
Oral administration subjects drugs to this process.
, 3. Which of the following describes an agonist's effect on a
receptor?
A. It binds to the receptor and blocks endogenous ligands.
B. It binds to the receptor and activates a biological response.
C. It binds to a different site to reduce the potency of the
drug.
D. It permanently deactivates the receptor site.
🟢 Correct answer B. It binds to the receptor and activates a
biological response.
🔴 Explanation: An agonist is a molecule that mimics the
action of a natural ligand by binding to a receptor and
triggering a specific cellular response.
4. A patient is taking Warfarin and is started on a drug that
is a potent inducer of the CYP450 enzyme system.
What is the most likely clinical outcome?
A. Increased risk of bleeding
B. Decreased therapeutic effect of Warfarin
C. Increased serum levels of Warfarin
D. No change in INR levels
QUESTIONS AND ANSWERS | VERIFIED AND WELL
DETAILED ANSWERS | PLUS RATIONALES |
GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains
Pharmacokinetics and Pharmacodynamics
Advanced Cardiovascular Pharmacology
Psychopharmacology and Neurology
Antimicrobial Stewardship and Infectious Disease
Endocrine and Metabolic Pharmacology
Pharmacogenomics and Precision Medicine
Legal and Ethical Prescribing Practices
Pain Management and Substance Use Disorders
Geriatric and Pediatric Considerations
Introduction
,This assessment is designed to evaluate the advanced
nursing student's proficiency in clinical pharmacology and
safe prescribing practices. The exam covers foundational
theoretical principles, such as drug metabolism and receptor
affinity, while emphasizing the practical application of
pharmacotherapeutics in diverse patient populations.
Students will be assessed on their ability to navigate complex
clinical scenarios, adhere to regulatory and legal standards,
and exercise sound ethical judgment in medication
management. The multi-choice format integrates critical
thinking and evidence-based decision-making to ensure
candidates are prepared for the rigors of advanced practice
and real-world clinical environments.
SECTION ONE: QUESTIONS 1–100
1. A patient with chronic kidney disease (CKD) requires a
medication that is primarily cleared by the kidneys.
Which pharmacokinetic process is most significantly
altered?
A. Absorption
B. Distribution
,C. Metabolism
D. Elimination
🟢 Correct answer D. Elimination
🔴 Explanation: Elimination refers to the removal of a drug
from the body, primarily through the kidneys. In CKD, the
glomerular filtration rate is reduced, leading to decreased
clearance and a higher risk of toxicity.
2. A patient is prescribed a drug with a high first-pass
effect. Which route of administration would result in the
lowest bioavailability?
A. Oral
B. Sublingual
C. Intravenous
D. Transdermal
🟢 Correct answer A. Oral
🔴 Explanation: The first-pass effect occurs when a drug is
metabolized by the liver after being absorbed from the
gastrointestinal tract but before reaching systemic circulation.
Oral administration subjects drugs to this process.
, 3. Which of the following describes an agonist's effect on a
receptor?
A. It binds to the receptor and blocks endogenous ligands.
B. It binds to the receptor and activates a biological response.
C. It binds to a different site to reduce the potency of the
drug.
D. It permanently deactivates the receptor site.
🟢 Correct answer B. It binds to the receptor and activates a
biological response.
🔴 Explanation: An agonist is a molecule that mimics the
action of a natural ligand by binding to a receptor and
triggering a specific cellular response.
4. A patient is taking Warfarin and is started on a drug that
is a potent inducer of the CYP450 enzyme system.
What is the most likely clinical outcome?
A. Increased risk of bleeding
B. Decreased therapeutic effect of Warfarin
C. Increased serum levels of Warfarin
D. No change in INR levels
